Analytical variables affecting analysis of Fisoprostanes and Fneuroprostanes in human cerebrospinal fluid by gas chromatography/mass spectrometry

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Yen, Hsiu Chuan ^a   Wei, Hsing Ju ^a   Chen, Ting Wei ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROSTANE DERIVATIVE; NEUROPROSTANE; BIOLOGICAL MARKER;

ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; HIGH TEMPERATURE; HUMAN; ION MONITORING; LIPID PEROXIDATION; MASS FRAGMENTOGRAPHY; NORMOTENSIVE HYDROCEPHALUS; QUANTITATIVE ANALYSIS; SOLID PHASE EXTRACTION; SUBARACHNOID HEMORRHAGE; URINALYSIS; BRAIN; OXIDATIVE STRESS; REFERENCE VALUE; STANDARDS; STANDARD;

BIOLOGICAL MARKERS; BRAIN; F2-ISOPROSTANES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIPID PEROXIDATION; NEUROPROSTANES; OXIDATIVE STRESS; REFERENCE VALUES;

EID: 84881497320     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/810915     Document Type: Article

References (31)

1. Halliwell B., Gutteridge M. C., Free Radicals in Biology and Medicine 2007 New York, NY, USA Oxford University Press
2. Roberts L. J. II, Morrow J. D., The generation and actions of isoprostanes. Biochimica et Biophysica Acta 1997 1345 2 121 135 2-s2.0-0031127031 10.1016/S0005-2760(96)00162-2 (Pubitemid 27138414)
3. 2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. Journal of Biological Chemistry 2006 281 8 4616 4623 2-s2.0-33646142645 10.1074/jbc.M507340200 (Pubitemid 43847720)
4. Jahn U., Galano J.-M., Durand T., Beyond prostaglandins-chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids. Angewandte Chemie 2008 47 32 5894 5955 2-s2.0-51449093769 10.1002/anie.200705122
5. Milne G. L., Yin H., Hardy K. D., Davies S. S., Roberts L. J., Isoprostane generation and function. Chemical Reviews 2011 111 10 5973 5996 2-s2.0-80054080478 10.1021/cr200160h
6. Milne G. L., Yin H., Morrow J. D., Human biochemistry of the isoprostane pathway. Journal of Biological Chemistry 2008 283 23 15533 15537 2-s2.0-47049114843 10.1074/jbc.R700047200
7. 2-isoprostanes as an index of oxidative stress in vivo. Free Radical Biology and Medicine 2000 28 4 505 513 2-s2.0-0034652768 10.1016/S0891-5849(99)00264-6 (Pubitemid 30136031)
8. Roberts L. J. II, Montine T. J., Markesbery W. R., Tapper A. R., Hardy P., Chemtob S., Dettbarn W. D., Morrow J. D., Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. Journal of Biological Chemistry 1998 273 22 13605 13612 2-s2.0-0032577553 10.1074/jbc.273.22.13605 (Pubitemid 28268404)
9. Yin H., Musiek E. S., Gao L., Porter N. A., Morrow J. D., Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo. Journal of Biological Chemistry 2005 280 28 26600 26611 2-s2.0-22544450518 10.1074/jbc.M503088200 (Pubitemid 41022258)
10. Montine K. S., Quinn J. F., Zhang J., Fessel J. P., Roberts L. J. II, Morrow J. D., Montine T. J., Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chemistry and Physics of Lipids 2004 128 1-2 117 124 2-s2.0-0842346368 10.1016/j.chemphyslip.2003.10.010 (Pubitemid 38167381)
11. 2-isoprostanes as a biomarker of oxidative stress. Nature Protocols 2007 2 1 221 226 2-s2.0-34347251604 10.1038/nprot.2006.375 (Pubitemid 47040087)
12. 2- isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method. Free Radical Biology and Medicine 2009 47 8 1101 1107 2-s2.0-70249127865 10.1016/j.freeradbiomed.2009.07. 028
13. 4-neuroprostanes levels in cerebrospinal fluid with outcome of aneurysmal subarachnoid hemorrhage in humans. Free Radical Biology and Medicine 2009 47 6 814 824 2-s2.0-68549103999 10.1016/j.freeradbiomed.2009.06.026
14. 2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods in Enzymology 2007 433 113 126 2-s2.0-38449117165 10.1016/S0076-6879(07)33006-1
15. Arneson K. O., Roberts L. J. II, Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans. Methods in Enzymology 2007 433 127 143 2-s2.0-38449114957 10.1016/S0076-6879(07)33007-3
16. 4-neuroprostanes in clinical studies. Journal of Biomedical Laboratory Science 2010 22 1 1 10
17. 2- isoprostanes following aneurysmal subarachnoid hemorrhage in humans. Free Radical Biology and Medicine 2006 40 8 1466 1473 2-s2.0-33646035846 10.1016/j.freeradbiomed.2005.12.019
18. Corcoran T. B., Mas E., Barden A. E., Durand T., Galano J.-M., Roberts L. J., Phillips M., Ho K. M., Mori T. A., Are isofurans and neuroprostanes increased after subarachnoid hemorrhage and traumatic brain injury? Antioxidants and Redox Signaling 2011 15 10 2663 2667 2-s2.0-80054012095 10.1089/ars.2011.4125
19. 2- isoprostanes as biomarkers of late-onset Alzheimer's disease. Journal of Molecular Neuroscience 2007 33 1 114 119 2-s2.0-35348817935 10.1007/s12031-007- 0044-1 (Pubitemid 47574948)
20. 2-isoprostanes are elevated in Huntington's disease. Neurology 1999 52 5 1104 1105 2-s2.0-0033596751 (Pubitemid 29161638)
21. De Leon M. J., Mosconi L., Li J., De Santi S., Yao Y., Tsui W. H., Pirraglia E., Rich K., Javier E., Brys M., Glodzik L., Switalski R., Saint Louis L. A., Pratico D., Longitudinal CSF isoprostane and MRI atrophy in the progression to AD. Journal of Neurology 2007 254 12 1666 1675 2-s2.0-37749016410 10.1007/s00415-007-0610-z
22. 2-isoprostanes and isofurans using gas chromatography-mass spectrometry. Free Radical Biology & Medicine 2013 59 36 44
23. 2t- isoprostane. Journal of Biomedical Laboratory Science 2001 13 24 28
24. 2-isoprostanes by gas chromatography-mass spectrometry is confounded by interfering substances. Free Radical Research 2010 44 2 191 198 2-s2.0-74549184543 10.3109/10715760903390838
25. 2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxidants and Redox Signaling 2008 10 8 1405 1434 2-s2.0-51749090447 10.1089/ars.2007.1956
26. 2-isoprostane concentration in probable AD. Neurology 1999 52 3 562 565 2-s2.0-0032588611 (Pubitemid 29075604)
27. 4-neuroprostanes levels in cerebrospinal fluid of patients with traumatic brain injury. Free Radical Biology & Medicine 2009 47 Abstract S108
28. 4-neuroprostanes from excitotoxicity and innate immune response in vivo by α-or γ -tocopherol. Journal of Chromatography B 2005 827 1 88 93 2-s2.0-27644574348 10.1016/j.jchromb.2005.03.037 (Pubitemid 41551601)
29. Milne G. L., Morrow J. D., Picklo M. J. Sr., Elevated oxidation of docosahexaenoic acid, 22:6 (n-3), in brain regions of rats undergoing ethanol withdrawal. Neuroscience Letters 2006 405 3 172 174 2-s2.0-33746882444 10.1016/j.neulet.2006.06.058 (Pubitemid 44189716)
30. Zhang Y., Milatovic D., Aschner M., Feustel P. J., Kimelberg H. K., Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity. Experimental Neurology 2007 204 2 819 827 2-s2.0-33947676341 10.1016/j.expneurol.2007.01.015 (Pubitemid 46497069)
31. 4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease. Journal of Neurochemistry 1999 72 2 734 740 2-s2.0-0032586942 10.1046/j.1471-4159.1999.0720734.x (Pubitemid 29055237)